Any malignant growth observed on the skin or tissues of the penis may lead to Penile Cancer. It accounts for up to a tenth of cancers detected in men in many countries Asia, African and South American countries and is rarely observed in the developed world.

Penile cancer diagnosis usually involves physical examination consisting of general body check and checking penis for signs of lumps or warts and checking patient’s history to ascertain similar previous occurrences and even patient’s habits and hygiene practices can be used to determine if a patient may or may not be affected with cancer. The removal of tissue from the affected region for study under a microscope, or biopsy, is also performed by pathologists to check for signs of cancer in the tissue sample. Cancer spreads to other parts of the body from the original tumor through tissue, lymph system or through blood and may cause formation of another tumor at a different location.

Penile cancer has been broadly classified into several types based on the type of cell cancer developed from which is determined by conducting tissue biopsy. There are broadly five types of penile cancers that have been observed, they are squamous cell cancer, basal cell cancer, adinocarcinome, sarcoma and melanoma of the penis. Based on the cases observed, penile cancer has been divided into five stages depending on the location and spread of malignant cells and whether it is recurrent or not.

Treatment of penile cancer is dependent on the staging and may include surgery, radiation therapy, biological therapy or chemotherapy. Surgical methods may involve surgically cutting away or burning of cancer cells using a laser along with a few healthy tissues or even involves partial amputation. Radiation therapy is carried out in tandem to surgery to ensure complete elimination of cancerous cells and to inhibit recurrence of cancer in the patient. If suggested by the physician a combination of chemotherapy and invasive surgery may also be opted for.

Penile cancer affects a minor population of the total cancer affected people in the developed countries but forms up to a tenth of all the cancer affected patients in the continents of Asia, Africa and South America. Once diagnosed the chances of recovery may further be reduced with factors like age, whether the cancer has been diagnosed for the first time or is recurring, the stage at which cancer is detected and tumor size and location.

For more information visit:

Author's Bio: 

Powers Taylor LLP is a boutique litigation firm that represents people injured by unsafe drugs. The attorneys of Powers Taylor founded this firm to focus on client needs. We employ unique and creative litigation strategies to obtain decisive results for our clients.